Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Onconetix, Inc. (ONCO)

Onconetix advances additional $500,000 to Realbotix under $5.0 million loan note

Neutral Impact 2 of 5 financing Written later

Onconetix made an additional $500,000 advance to its subsidiary Realbotix, LLC on October 22, 2026, under a Grid Promissory Note dated September 11, 2026. Outstanding principal under the note is now $3.0 million of a up to $5.0 million facility, and the note's terms are unchanged.

Key points

  • Additional advance of $500,000 made October 22, 2026 to Realbotix, LLC
  • Aggregate principal outstanding under the Grid Promissory Note is $3.0 million
  • Total facility allows loans of up to $5.0 million; $2.5 million was advanced on September 11, 2026
  • Terms of the note remain unchanged from the September 14, 2026 Form 8-K disclosure

The filing

CompanyOnconetix, Inc. (ONCO)
Form8-K, current report
Filed with the SECOct 23, 2026, 11:40 AM ET
Accession number0001213900-26-111944

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 23, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.